Duration of the dormant state in an established cell line of human hematopoietic cells.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Cancer Research

• Publication date

  1977-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 336195
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.

  1977cited by this paper
• Multiplication and Division in Mammalian Cells

  1977cited by this paper
• Cell kill kinetics with hydroxyurea.

  1976cited by this paper
• Computer simulation of leukemia therapy: combined pharmacokinetics, intracellular enzyme kinetics, and cell kinetics of the treatment of L1210 leukemia by cytosine arabinoside.

  1976cited by this paper
• Trisomy of chromosome 15 in spontaneous leukemia of AKR mice.

  1975cited by this paper
• Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.

  1975cited by this paper
• Disposition of cytosine arabinoside (NSC-63878) and its metabolites: a pharmacokinetic simulation.

  1975cited by this paper
• The kinetic significance of cell size, I. Variation of cell cycle parameters with size measured at mitosis.

  1975cited by this paper
• The Epstein-Barr virus and neoplasia.

  1975cited by this paper
• The kinetic significance of cell size. II. Size distributions of resting and proliferating cells during interphase.

  1975cited by this paper
• Evaluation of a Feulgen- type reaction in suspension using flow microfluorimetry and a cell separation technique.

  1975cited by this paper
• Comparative inhibition of purified DNA polymerases from murine leukemia virus and human lymphocytes by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.

  1974cited by this paper
• FLOW MICROFLUOROMETRIC ANALYSIS OF CELL KILLING WITH CYTOTOXIC DRUGS

  1974cited by this paper
• Computer analysis of tracer kinetic data from a human hematopoietic cell line during different phases of growth.

  1974cited by this paper
• Microfluorimetric evaluation of cell kill kinetics with 1-beta-D-arabinofuranosylcytosine.

  1974cited by this paper
• Pharmacodynamic and pharmacokinetic measurements of antitumor agents

  1974cited by this paper
• Kinetics of effect of 1-beta-D-arabinofuranosylcytosine, its 5'-palmitoyl ester, 1-beta-D-arabinofuranosyluracil, and tritiated thymidine on the viability of cultured leukemia L1210 cells.

  1972cited by this paper
• Use of cell separation at 1 g for cytokinetic studies in spontaneous AKR leukemia.

  1972cited by this paper
• Kinetic and template studies with 1- -D-arabinofuranosylcytosine 5'-triphosphate and mammalian deoxyribonucleic acid polymerase.

  1972cited by this paper
• Cell cycle phase specificity of antitumor agents.

  1972cited by this paper
• Identity and proliferation of small lymphocyte precursors in cultures of lymphocyte-rich fractions of guinea pig bone marrow.

  1971cited by this paper
• Methotrexate pharmacokinetics.

  1971cited by this paper
• Proliferative kinetics of human hematopoietic cells during different growth phases in vitro.

  1971cited by this paper
• CYTOKINETIC ANALYSIS of SLOWLY PROLIFERATING BONE MARROW CELLS DURING RECOVERY FROM RADIATION INJURY

  1971cited by this paper
• Perturbation of generation cycle of human leukemic myeloblasts in vivo by methotrexate.

  1971cited by this paper
• The Automatic Analysis of Flm Curves

  1971cited by this paper
• Attempted recruitment of leukemic myeloblasts to proliferative activity by sequential drug treatment

  1971cited by this paper
• Changing concepts of treatment in acute leukemia.

  1971cited by this paper
• 2 morphologically and kinetically distinct populations of lymphoid cells in the bone marrow.

  1970cited by this paper
• Proliferative capacity of leukemic cells in AKR leukemia.

  1970cited by this paper
• Two Morphologically and Kinetically Distinct Populations of Lymphoid Cells in the Bone Marrow

  1970cited by this paper
• Studies on drug resistance. II. Kinase patterns in P815 neoplasms sensitive and resistant to 1-beta-D-arabinofuranosylcytosine.

  1970cited by this paper
• Mean, geometric mean, or median grain count in cell cycle studies.

  1970cited by this paper
• Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.

  1970cited by this paper
• Studies of cellular proliferation in human leukemia. IV. Behavior of normal hematopoietic cells in 3 adults with acute leukemia given continuous infusions of3 H‐thymidine for 8 or 10 days

  1970cited by this paper
• Studies of cellular proliferation in human leukemia. III. Behavior of leukemic cells in three adults with acute leukemia given continuous infusions of 3H‐thymidine for 8 or 10 days

  1970cited by this paper
• Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.

  1970cited by this paper
• Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults.

  1969cited by this paper
• The mechanism of induction of complete remission in acute myeloblastic leukemia in man.

  1969cited by this paper
• The thymidine-14C and -3H double-labeling technic in the study of the cell cycle of L1210 leukemia ascites tumor in vivo.

  1969cited by this paper
• Toxicity studies in mice treated with 1-beta-D-arabinofuranosylcytosine (ara-C).

  1969cited by this paper
• Cell Proliferation in the Intestinal Epithelium

  1969cited by this paper
• Studies on the persistence of methotrexate, cytosine arabinoside, and leucovorin in serum of mice.

  1969cited by this paper
• Discussion Magnitude of Proliferating Fraction and Rate of Proliferation of Populations of Leukemic Cells in Man

  1969cited by this paper
• Cytotoxic Effects of 1-β-d-Arabinofuranosyl-5-fluorocytosine and of 1-β-d-Arabinofuranosylcytosine in Proliferating Tissues in Mice

  1969cited by this paper
• Studies on the mechanism of action of 1-beta-D-arabinofuranosylcytosine as an inhibitor of DNA synthesis in human leukemic leukocytes.

  1969cited by this paper
• S-phase cells of rapidly growing and resting populations. Differences in response to methotrexate.

  1969cited by this paper
• Heterotransplantation of human cell lines from Burkitt's tumors and acute leukemia into newborn rats

  1969cited by this paper
• Correction for threshold error in the determination of generation times by the grain-count halving method.

  1969cited by this paper
• Separation of cells by velocity sedimentation

  1969cited by this paper
• Heterotransplantability of human cell lines derived from leukemia and lymphomas into immunologically tolerant rats

  1969cited by this paper
• Inhibition of mammalian DNA polymerase by the 5'-triphosphate of 1-beta-d-arabinofuranosylcytosine and the 5'-triphosphate of 9-beta-d-arabinofuranoxyladenine.

  1968cited by this paper
• Inhibition of Mammalian DNA Polymerase by the 5′-Triphosphate of 1-β-d-Arabinofuranosylcytosine and the 5′-Triphosphate of 9-β-d-Arabinofuranosyladenine

  1968cited by this paper
• Estimating the median generation time of proliferating cell systems in steady state.

  1968cited by this paper
• Studies on unbalanced growth in synchronized HeLa cells.

  1968cited by this paper
• The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y).

  1968cited by this paper
• The cell cycle of leukemia L1210 cells in vivo.

  1967cited by this paper
• Transport and Phosphorylation as Factors in the Antitumor Action of Cytosine Arabinoside

  1967cited by this paper
• Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine.

  1967cited by this paper
• Continuous culture of seven new cell lines (SK‐L1 to 7) from patients with acute leukemia

  1967cited by this paper
• Effect of antimetabolites on kinetic behavior of proliferating cultured L1210 leukemia cells.

  1967cited by this paper
• Formal discussion: on the cellular origins and distinctive features of cultured cell lines derived from patients with leukemias and lymphomas.

  1967cited by this paper
• Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.

  1967cited by this paper
• Experimental evaluation of potential anticancer agents XV. On the relative rates of growth and host kill of "single" leukemia cells that survive in vivo cytoxan therapy.

  1966cited by this paper
• The effects of chemotherapy on the kinetics of leukemic cell behavior.

  1965cited by this paper
• COMPARATIVE STUDIES OF LEUKEMIC CELLS SENSITIVE AND RESISTANT TO CYTOSINE ARABINOSIDE.

  1965cited by this paper
• THE EFFECT OF DIFFERING DEMANDS FOR BLOOD CELL PRODUCTION ON DNA SYNTHESIS BY HEMOPOIETIC COLONY-FORMING CELLS OF MICE.

  1965cited by this paper
• Metabolism of 1-beta-D-arabinofuranosylcytosine in L cells.

  1965cited by this paper
• Experimental evaluation of potential anticancer agents. 28. Effects of therapy on viability and rate of proliferation of leukemic cells in various anatomic sites.

  1965cited by this paper
• Kinetic Model of a Bone‐Marrow Stem‐Cell Population

  1962cited by this paper
• A proposed mechanism of action of 1-beta-D-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cells.

  1962cited by this paper
• The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice.

  1960cited by this paper
• Cell population kinetics in the intestinal epithelium of the mouse.

  1959cited by this paper
• Atomic Radiation and Life

  1957cited by this paper

• Cancer as a Disease of Development Gone Awry

  2023cites this paper
• Cancer Stem Cells: Formidable Allies of Cancer

  2015cites this paper
• Leukemia stem cells in 2010: current understanding and future directions.

  2011cites this paper
• Growth patterns of human acute lymphoblastic leukaemia in diffusion chambers befor treatment and after cessation of therapy.

  2009cites this paper
• The Elusive Goal: Presidential Address1

  2006cites this paper
• Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies

  2003cites this paper
• Anomalistic Signaling as a Possible Biochemical Explanation for Discordant Maturation in Chronic Myelogenous Leukemia (CML)

  1998cites this paper
• New understanding of the pathogenesis of CML: a prototype of early neoplasia

  1997cites this paper
• Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia.

  1990cites this paper
• Commentary. Looking back

  1989cites this paper
• Treatment sequencing, asymmetry, and uncertainty: protocol strategies for combination chemotherapy.

  1986cites this paper
• Current status of treatment of acute leukemia in adults: an overview of the Memorial experience and review of literature.

  1986cites this paper
• Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens.

  1986cites this paper
• Cell kinetics of leukemia.

  1986cites this paper
• Recent advances in the treatment of acute lymphoblastic leukemia in adults and future prospects.

  1985cites this paper
• Thymidylate synthase inhibition in cells with arrested DNA synthesis is not due to an allosteric interaction in the replitase complex.

  1985cites this paper
• Acute lymphoblastic leukemia in adults.

  1985cites this paper
• Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.

  1984cites this paper
• Thymidineas a Kineticand BiochemicalModulatorof 1-ß-D-Arabinofuranosy Icytosine in Human Acute NonlymphocyticLeukemia1

  1984cites this paper
• Current Status of Treatment of Acute Leukemia in Adults: An Overview

  1984cites this paper
• Human myeloma in vitro colony growth: interrelationships between drug sensitivity, cell kinetics, and patient survival duration.

  1983cites this paper
• Recovery of HeLa cell population growth after treatment with 5,6‐dichloro‐1‐β‐D‐ribofuranosylbenzimidazole (DRB)

  1983cites this paper
• 2nd Gordon Hamilton Fairley Lecture

  1982cites this paper
• Rearrangement in rDNA-bearing chromosomes in cell lines from neoplastic cells.

  1982cites this paper
• INACCURACY OF ESTIMATIONS OF S PHASE FRACTION BY REDUCTION IN CLONING EFFICIENCY WITH HYDROXYUREA OR TRITIATED THYMIDINE

  1981cites this paper
• The tumor dormant state.

  1981cites this paper
• The elusive goal: presidential address.

  1981cites this paper
• An in vitro model for acute myelogenous leukemia chemotherapy

  1981cites this paper
• Effects of thymidine and thymidine plus 5-fluorouracil on the growth kinetics of a human lymphoid cell line.

  1980cites this paper
• A long‐term clinical follow‐up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens

  1980cites this paper
• Prevention of Central Nervous System Leukaemia in Acute Lymphoblastic Leukaemia with Prophylactic Chemotherapy Alone

  1979cites this paper
• The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice

  1979cites this paper
• [Metabolism of proliferating and resting cells].

  1979cites this paper
• Potentiation of vincristine cytotoxicity by hormones: Corticosteroids, androgens, estrogens and progestins

  1978cites this paper